insys therapeutics insys therapeutics
Stories About

insys therapeutics

Insys, the maker of fentanyl-based Subsys, agreed to a $225 million settlement with the federal government to resolve criminal and civil investigations of the company's role in the opioid crisis. Reuters hide caption

toggle caption
Reuters

Insys Therapeutics founder John Kapoor (center) departs federal court in Boston in January. The criminal trial of Kapoor and four other executives from the company wrapped up on Friday. Steven Senne/AP hide caption

toggle caption
Steven Senne/AP

Criminal Trial Of Opioid-Peddling Drug Company Execs Goes To The Jury

  • Download
  • <iframe src="https://www.npr.org/player/embed/710454888/710462976" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript